Text Size

Improving Prevention of Heart Disease in Latinos (LUCHAR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by National Heart, Lung, and Blood Institute (NHLBI).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00101530
First received: January 10, 2005
Last updated: April 27, 2009
Last verified: April 2009
History of Changes
  Purpose

The purpose of the study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, it seeks to improve the primary prevention of CVD in Hispanics.


Condition
Cardiovascular Diseases
Heart Diseases
Hypertension
Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Latinos Using Cardio Health Actions to Reduce Risk

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Enrollment: 179
Study Start Date: September 2004
Estimated Study Completion Date: September 2009
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

White and Latino patients in a safety net hospital

Criteria

Eligibility Criteria vary with each study.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00101530

Locations
United States, Colorado
Denver Health Medical Center
Denver, Colorado, United States, 80204
Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Edward Havranek, MD Denver Health and Hospital Authority
Principal Investigator: Sheana Bull, PhD University of Colorado Denver/HSC Aurora
  More Information

No publications provided

Responsible Party: Edward P. Havranek, MD, Denver Health Medical Center
ClinicalTrials.gov Identifier: NCT00101530     History of Changes
Other Study ID Numbers: 1285, U01 HL79160, U01 HL79208
Study First Received: January 10, 2005
Last Updated: April 27, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Diabetes Mellitus
Heart Diseases
Hypertension
 Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013